Adello Biologics

At Adello, our vision is to provide high-quality, affordable #biosimilars to patients worldwide.

[Adello Biologics @AdelloBio]

Adello Welcomes Chintu Patel as it's new CEO! https://t.co/FuDG4YG3na via @AdelloBio

[Adello Biologics @AdelloBio]

FDA Accepts Adello’s #Biosimilar Biologics License Application for a Proposed Filgrastim Biosimilar #biosimilars https://t.co/4XZ7SDnN7n

[Adello Biologics @AdelloBio]

Our CEO speaks about Adello's singular focus on #biosimilars and building a company culture from the bottom up. https://t.co/tC5LxsseJM

[Adello Biologics @AdelloBio]

Read more about our name change: https://t.co/xPrrCBAl7C

[Adello Biologics @AdelloBio]

We're pleased to announce our new name and identity: Adello Biologics. This change reflects an exciting step in the evolution of our company

[Adello Biologics @AdelloBio]

We're happy to welcome our new Chief Scientific Officer, Dr. Michael W. Washabaugh, to the TPI family https://t.co/Sy6ljyaRrs

[Adello Biologics @AdelloBio]

Biosimilars are helping to make #healthcare more affordable. Learn more about #biosimilars on our website: https://t.co/ND9Nx1xQ8B

[Adello Biologics @AdelloBio]

We're happy to welcome our new CEO, Dr. Peter Moesta, to the TPI family. Read more:
https://t.co/r7kyYMRDFQ